The pharmaceutical packaging market is set to be worth $158.8 billion by 2025, research shows

By Catherine Sturman
US based research company Grand View Research Inc has recently undertaken a study within the pharmaceutical packaging market. With the growing demand of...

US based research company Grand View Research Inc has recently undertaken a study within the pharmaceutical packaging market. With the growing demand of pharmaceuticals, the use of product packaging is also growing at a steady rate.

The growing pharmaceutical industry has therefore placed a significant role in the health industry, supporting the distribution of essential drugs and medicines from contamination, counterfeiting, amongst other forms of damage. For example, the aluminium foil material division is projected to grow at a CAGR of 7.2 percent by 2025.

Developed countries, such as the US, China and European countries currently dominate this space, where demand for these products are expected to grow rapidly on account of fortification of medicines and drugs against exterior impacts.

However, packaging materials and products will need to bear the brunt of stringent government regulations, against a continued growing market for counterfeit pharmaceuticals. These remain a key threat to manufacturers and consumers who look for drugs at cheaper prices.

North America has especially become a dominant force in the market, and is supported by a thriving pharmaceutical industry and rapid new product introductions. The paper and paperboard division is predicted to reach $40.83 billion by 2025, according to the study, as a result of a growing demand in secondary packaging projects.

Asia Pacific is also anticipated to grow rapidly on account of rising pharmaceutical manufacturing in China and India, with a predicted market share of 33 percent by 2025. The growing trend of contract packaging in the pharmaceutical industry is expected to further augment market growth in Asia Pacific.

For further information: http://www.grandviewresearch.com/industry-analysis/pharmaceutical-packaging-market

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19